The effect of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) and charybdotoxin (CTX) on relaxations of isolated cerebral arteries to nitric oxide.

作者: Hisashi Onoue , Zvonimir S. Katusic

DOI: 10.1016/S0006-8993(97)01393-0

关键词:

摘要: The mechanism underlying smooth muscle relaxations of cerebral arteries in response to nitric oxide is still not completely understood. present study was designed determine the role soluble guanylate cyclase a oxide/nucleophile complex, diethylaminodiazen-1-ium-1,2-dioate (DEA-NONOate). Rings canine middle without endothelium were suspended Krebs-Ringer bicarbonate solution for isometric tension recording. levels guanosine 3',5'-cyclic monophosphate (cyclic GMP) measured by radioimmunoassay technique. During contractions uridine 5'-triphosphate (UTP), DEA-NONOate (10(-10) 10(-5) M) caused concentration-dependent relaxations. Measurements cyclic GMP arterial wall demonstrated that potent stimulator and subsequent formation GMP. Increasing concentrations selective inhibitor, 1H-[1,2,4]-oxadiazolo[4,3-a]quinoxalin-1-one (ODQ), reduction both production DEA-NONOate. Interestingly, presence highest concentration (3 x 10(-6) ODQ, M abolished, whereas same almost complete relaxation, suggesting mechanisms independent may mediate relaxing effect high donor. A Ca2+-activated potassium channel blocker charybdotoxin (CTX) significantly reduced resistant supporting idea activate channels independently results our suggest under physiological conditions, key mediator oxide. However, pathological conditions associated with induction synthase increased biosynthesis (e.g., ischemia, inflammation, sepsis), other than be activated.

参考文章(35)
J W Daly, K B Seamon, Forskolin: a unique diterpene activator of cyclic AMP-generating systems Journal of cyclic nucleotide research. ,vol. 7, pp. 201- 224 ,(1981)
A L Harris, P J Silver, R G Bentley, M H Perrone, B M Lemp, L T Hamel, Phosphodiesterase isozyme inhibition and the potentiation by zaprinast of endothelium-derived relaxing factor and guanylate cyclase stimulating agents in vascular smooth muscle. Journal of Pharmacology and Experimental Therapeutics. ,vol. 249, pp. 394- 400 ,(1989)
M. T. Nelson, J. M. Quayle, Physiological roles and properties of potassium channels in arterial smooth muscle American Journal of Physiology-cell Physiology. ,vol. 268, ,(1995) , 10.1152/AJPCELL.1995.268.4.C799
Uwe Koedel, Andrea Bernatowicz, Robert Paul, Karl Frei, Adriano Fontana, Hans-Walter Pfister, Experimental pneumococcal meningitis: cerebrovascular alterations, brain edema, and meningeal inflammation are linked to the production of nitric oxide. Annals of Neurology. ,vol. 37, pp. 313- 323 ,(1995) , 10.1002/ANA.410370307
Z S Katusic, J T Shepherd, P M Vanhoutte, Vasopressin causes endothelium-dependent relaxations of the canine basilar artery. Circulation Research. ,vol. 55, pp. 575- 579 ,(1984) , 10.1161/01.RES.55.5.575
F M Faraci, J E Brian, Nitric oxide and the cerebral circulation. Stroke. ,vol. 25, pp. 692- 703 ,(1994) , 10.1161/01.STR.25.3.692
Chris M. Maragos, Deborah Morley, David A. Wink, Tambra M. Dunams, Joseph E. Saavedra, Aaron Hoffman, Alfred A. Bove, Lawrence Isaac, Joseph A. Hrabie, Larry K. Keefer, Complexes of 'NO with Nucleophiles as Agents for the Controlled Biological Release of Nitric Oxide. Vasorelaxant Effects Journal of Medicinal Chemistry. ,vol. 34, pp. 3242- 3247 ,(1991) , 10.1021/JM00115A013
Masami Ueno, Tony J.-F. Lee, Endotoxin decreases the contractile responses of the porcine basilar artery to vasoactive substances. Journal of Cerebral Blood Flow and Metabolism. ,vol. 13, pp. 712- 719 ,(1993) , 10.1038/JCBFM.1993.90
M. L. Garcia, G. Gimenez-Gallego, M. A. Navia, J. P. Reuben, G. M. Katz, G. J. Kaczorowski, Purification, sequence, and model structure of charybdotoxin, a potent selective inhibitor of calcium-activated potassium channels Proceedings of the National Academy of Sciences of the United States of America. ,vol. 85, pp. 3329- 3333 ,(1988) , 10.1073/PNAS.85.10.3329
R. M. J. Palmer, A. G. Ferrige, S. Moncada, Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor Nature. ,vol. 327, pp. 524- 526 ,(1987) , 10.1038/327524A0